InvestorsHub Logo
Post# of 252426
Next 10
Followers 10
Posts 1097
Boards Moderated 0
Alias Born 08/23/2004

Re: DewDiligence post# 113911

Friday, 02/04/2011 10:20:52 AM

Friday, February 04, 2011 10:20:52 AM

Post# of 252426
Dew, at what point will you drag yourself out of the all-oral HCV ditch and realize that the position is becoming more difficult to defend. Three drugs may work, but at what cost and at what risk of mounting side effects? In order to get a permanent remission or cure from HCV, the immune system needs to be engaged and that is what the interferon appears to do. The problem with the oral drugs is the vast number of viral particles that have to be inhibited to achieve remission, and the drugs that are designed to attack the viral proteins will also find targets on normal human proteins. It's a difficult design problem and while someone somewhere might come up with the right combo, eventually, it will be an expensive development program. Do yourself a favor and start thinking like a biologist and not an engineer.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.